{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:43:54Z","timestamp":1771512234678,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T00:00:00Z","timestamp":1382054400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s12149-013-0778-5","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T09:35:06Z","timestamp":1382002506000},"page":"33-41","source":"Crossref","is-referenced-by-count":3,"title":["A simple algorithm for subregional striatal uptake analysis with partial volume correction in dopaminergic PET imaging"],"prefix":"10.1007","volume":"28","author":[{"given":"Kun-Han","family":"Lue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Hon","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hao K.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Jen","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Hsin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keh-Shih","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"key":"778_CR1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMcp043908","volume":"353","author":"JG Nutt","year":"2005","unstructured":"Nutt JG, Wooten GF. Diagnosis and initial management of Parkinson\u2019s disease. N Engl J Med. 2005;353:1021\u20137.","journal-title":"N Engl J Med"},{"key":"778_CR2","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/brain\/awr177","volume":"134","author":"JL Cummings","year":"2011","unstructured":"Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain. 2011;134:3146\u201366.","journal-title":"Brain"},{"key":"778_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J. Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"778_CR4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","volume":"18","author":"I Litvan","year":"2003","unstructured":"Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord Off J Mov Disord Soc. 2003;18:467\u201386.","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"778_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s002590050374","volume":"26","author":"J Booij","year":"1999","unstructured":"Booij J, Tissingh G, Winogrodzka A, van Royen EA. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur J Nucl Med. 1999;26:171\u201382.","journal-title":"Eur J Nucl Med"},{"key":"778_CR6","first-page":"755","volume":"42","author":"M Ichise","year":"2001","unstructured":"Ichise M, Meyer JH, Yonekura Y. An introduction to PET and SPECT neuroreceptor quantification models. J Nucl Med. 2001;42:755\u201363.","journal-title":"J Nucl Med"},{"key":"778_CR7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.109.070094","volume":"51","author":"N Okamura","year":"2010","unstructured":"Okamura N, Villemagne VL, Drago J, Pejoska S, Dhamija RK, Mulligan RS, et al. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133. J Nucl Med. 2010;51:223\u20138.","journal-title":"J Nucl Med"},{"key":"778_CR8","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2967\/jnumed.110.078196","volume":"51","author":"KJ Lin","year":"2010","unstructured":"Lin KJ, Weng YH, Wey SP, Hsiao T, Lu CS, Skovronsky D, et al. Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent. J Nucl Med. 2010;51:1480\u20135.","journal-title":"J Nucl Med"},{"key":"778_CR9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"T Steeves","year":"2009","unstructured":"Steeves T, Miyasaki J, Zurowski M, Lang A, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009;132:1376\u201385.","journal-title":"Brain"},{"key":"778_CR10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00259-008-0989-5","volume":"36","author":"S Eshuis","year":"2009","unstructured":"Eshuis S, Jager P, Maguire R, Jonkman S, Dierckx R, Leenders K. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson\u2019s disease and healthy controls. Eur J Nucl Med Mol Imaging. 2009;36:454\u201362.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"778_CR11","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/mds.22484","volume":"24","author":"A Br\u00fcck","year":"2009","unstructured":"Br\u00fcck A, Aalto S, Rauhala E, Bergman J, Marttila R, Rinne JO. A follow-up study on 6-[18F] fluoro-l-dopa uptake in early Parkinson\u2019s disease shows nonlinear progression in the putamen. Mov Disord. 2009;24:1009\u201315.","journal-title":"Mov Disord"},{"key":"778_CR12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.nucmedbio.2007.02.005","volume":"34","author":"MJ Ribeiro","year":"2007","unstructured":"Ribeiro MJ, Ricard M, Li\u00e8vre MA, Bourgeois S, Emond P, Gervais P, et al. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [11C] PE2I in healthy volunteers. Nucl Med Biol. 2007;34:465\u201370.","journal-title":"Nucl Med Biol"},{"key":"778_CR13","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroimage.2006.06.058","volume":"33","author":"O Monchi","year":"2006","unstructured":"Monchi O, Hyun Ko J, Strafella AP. Striatal dopamine release during performance of executive functions: a [11C] raclopride PET study. Neuroimage. 2006;33:907\u201312.","journal-title":"Neuroimage"},{"key":"778_CR14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00259-005-0027-9","volume":"33","author":"A Jucaite","year":"2006","unstructured":"Jucaite A, Odano I, Olsson H, Pauli S, Halldin C, Farde L. Quantitative analyses of regional [11C] PE2I binding to the dopamine transporter in the human brain: a PET study. Eur J Nucl Med Mol Imaging. 2006;33:657\u201368.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"778_CR15","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00259-009-1357-9","volume":"37","author":"C Sioka","year":"2010","unstructured":"Sioka C, Fotopoulos A, Kyritsis AP. Recent advances in PET imaging for evaluation of Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2010;37:1594\u2013603.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"778_CR16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.73.5.517","volume":"73","author":"M Ghaemi","year":"2002","unstructured":"Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson\u2019s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry. 2002;73:517\u201323.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"778_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2967\/jnumed.108.061572","volume":"50","author":"P Jokinen","year":"2009","unstructured":"Jokinen P, Helenius H, Rauhala E, Br\u00fcck A, Eskola O, Rinne JO. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls. J Nucl Med. 2009;50:893\u20139.","journal-title":"J Nucl Med"},{"key":"778_CR18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/mds.1139","volume":"16","author":"E Nurmi","year":"2001","unstructured":"Nurmi E, Ruottinen HM, Bergman J, Haaparanta M, Solin O, Sonninen P, et al. Rate of progression in Parkinson\u2019s disease: a 6-[18F] fluoro-l-dopa PET study. Mov Disord. 2001;16:608\u201315.","journal-title":"Mov Disord"},{"key":"778_CR19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","volume":"54","author":"AL Whone","year":"2003","unstructured":"Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, et al. Slower progression of Parkinson\u2019s disease with ropinirole versus levodopa: the REAL-PET study. Ann Neurol. 2003;54:93\u2013101.","journal-title":"Ann Neurol"},{"key":"778_CR20","first-page":"1324","volume":"43","author":"V Dhawan","year":"2002","unstructured":"Dhawan V, Ma Y, Pillai V, Spetsieris P, Chaly T, Belakhlef A, et al. Comparative analysis of striatal FDOPA uptake in Parkinson\u2019s disease: ratio method versus graphical approach. J Nucl Med. 2002;43:1324\u201330.","journal-title":"J Nucl Med"},{"key":"778_CR21","first-page":"955","volume":"35","author":"S Takikawa","year":"1994","unstructured":"Takikawa S, Dhawan V, Chaly T, Robeson W, Dahl R, Zanzi I, et al. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. J Nucl Med. 1994;35:955\u201363.","journal-title":"J Nucl Med"},{"key":"778_CR22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MNM.0b013e32835fcd7f","volume":"34","author":"A Jaimini","year":"2013","unstructured":"Jaimini A, Tripathi M, D\u2019Souza MM, Panwar P, Sharma R, Mehta S, et al. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson\u2019s disease from atypical parkinsonian disorders. Nucl Med Commun. 2013;34:426\u201331.","journal-title":"Nucl Med Commun"},{"key":"778_CR23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2967\/jnumed.111.095224","volume":"53","author":"M Oh","year":"2012","unstructured":"Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, et al. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy. J Nucl Med. 2012;53:399\u2013406.","journal-title":"J Nucl Med"},{"key":"778_CR24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2377-11-35","volume":"11","author":"S Asari","year":"2011","unstructured":"Asari S, Fujimoto K, Miyauchi A, Sato T, Nakano I, Muramatsu S. Subregional 6-[18F]fluoro-L-m-tyrosine uptake in the striatum in Parkinson\u2019s disease. BMC Neurol. 2011;11:35.","journal-title":"BMC Neurol"},{"key":"778_CR25","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2967\/jnumed.109.071811","volume":"51","author":"C Fougere la","year":"2010","unstructured":"la Fougere C, Popperl G, Levin J, Wangler B, Boning G, Uebleis C, et al. The value of the dopamine D2\/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. J Nucl Med. 2010;51:581\u20137.","journal-title":"J Nucl Med"},{"key":"778_CR26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2967\/jnumed.106.035774","volume":"48","author":"M Soret","year":"2007","unstructured":"Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48:932\u201345.","journal-title":"J Nucl Med"},{"key":"778_CR27","first-page":"1715","volume":"43","author":"V Frouin","year":"2002","unstructured":"Frouin V, Comtat C, Reilhac A, Gregoire MC. Correction of partial-volume effect for PET striatal imaging: fast implementation and study of robustness. J Nucl Med. 2002;43:1715\u201326.","journal-title":"J Nucl Med"},{"key":"778_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0031-3203(98)00091-0","volume":"32","author":"C Studholme","year":"1999","unstructured":"Studholme C, Hill DLG, Hawkes DJ. An overlap invariant entropy measure of 3D medical image alignment. Pattern Recognit. 1999;32:71\u201386.","journal-title":"Pattern Recognit"},{"key":"778_CR29","unstructured":"Collignon A, Maes F, Delaere D, Vandermeulen D, Suetens P, Marchal G. Automated multi-modality image registration based on information theory. In: Bizais Y, Barillot C, Di Paolo R, editors. Information processing in medical imaging. Dordrecht: Kluwer Academic Publishers; 1995. p. 263\u201374."},{"key":"778_CR30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s12149-011-0533-8","volume":"25","author":"IC Chang","year":"2011","unstructured":"Chang IC, Lue KH, Hsieh HJ, Liu SH, Kao CHK. Automated striatal uptake analysis of 18F-FDOPA PET images applied to Parkinson\u2019s disease patients. Ann Nucl Med. 2011;25:796\u2013803.","journal-title":"Ann Nucl Med"},{"key":"778_CR31","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00259-006-0155-x","volume":"33","author":"L Tossici-Bolt","year":"2006","unstructured":"Tossici-Bolt L, Hoffmann SMA, Kemp PM, Mehta RL, Fleming JS. Quantification of [123I] FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging. 2006;33:1491\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"778_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1088\/0031-9155\/49\/14\/N03","volume":"49","author":"JS Fleming","year":"2004","unstructured":"Fleming JS, Bolt L, Stratford JS, Kemp PM. The specific uptake size index for quantifying radiopharmaceutical uptake. Phys Med Biol. 2004;49:227\u201334.","journal-title":"Phys Med Biol"},{"key":"778_CR33","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00259-011-1801-5","volume":"38","author":"L Tossici-Bolt","year":"2011","unstructured":"Tossici-Bolt L, Dickson JC, Sera T, de Nijs R, Bagnara MC, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 2011;38:1529\u201340.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"778_CR34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2967\/jnumed.112.110106","volume":"54","author":"TA Soderlund","year":"2013","unstructured":"Soderlund TA, Dickson JC, Prvulovich E, Ben-Haim S, Kemp P, Booij J, et al. Value of semiquantitative analysis for clinical reporting of 123I-2-beta-carbomethoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT Studies. J Nucl Med. 2013;54:714\u201322.","journal-title":"J Nucl Med"},{"key":"778_CR35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00004728-197906000-00001","volume":"3","author":"EJ Hoffman","year":"1979","unstructured":"Hoffman EJ, Huang SC, Phelps ME. Quantitation in positron emission computed tomography: 1. Effect of object size. J Comput Assist Tomogr. 1979;3:299\u2013308.","journal-title":"J Comput Assist Tomogr"},{"key":"778_CR36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00004728-198406000-00028","volume":"8","author":"RM Kessler","year":"1984","unstructured":"Kessler RM, Ellis JR Jr, Eden M. Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr. 1984;8:514\u201322.","journal-title":"J Comput Assist Tomogr"},{"key":"778_CR37","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12149-010-0463-x","volume":"25","author":"CHK Kao","year":"2011","unstructured":"Kao CHK, Hsu WL, Xie HL, Lin MC, Lan WC, Chao HY. GMP production of [18F] FDOPA and issues concerning its quality analyses as in USP \u201cFluorodopa F 18 Injection\u201d. Ann Nucl Med. 2011;25:309\u201316.","journal-title":"Ann Nucl Med"},{"key":"778_CR38","doi-asserted-by":"crossref","unstructured":"Stearns CW, McDaniel DL, Kohlmyer SG, Arul PR, Geiser BP, Shanmugam V. Random coincidence estimation from single event rates on the Discovery ST PET\/CT scanner. IEEE Nucl Sci Symp Conf Rec; 2003. p. 3067\u20139.","DOI":"10.1109\/NSSMIC.2003.1352545"},{"key":"778_CR39","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1109\/TNS.2002.1039554","volume":"49","author":"S Wollenweber","year":"2002","unstructured":"Wollenweber S. Parameterization of a model-based 3-D PET scatter correction. IEEE Trans Nucl Sci. 2002;49:722\u20137.","journal-title":"IEEE Trans Nucl Sci"},{"key":"778_CR40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1109\/42.363108","volume":"13","author":"HM Hudson","year":"1994","unstructured":"Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13:601\u20139.","journal-title":"IEEE Trans Med Imaging"},{"key":"778_CR41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1118\/1.597290","volume":"21","author":"IG Zubal","year":"1994","unstructured":"Zubal IG, Harrell CR, Smith EO, Rattner Z, Gindi G, Hoffer PB. Computerized three-dimensional segmented human anatomy. Med Phys. 1994;21:299\u2013302.","journal-title":"Med Phys"},{"key":"778_CR42","doi-asserted-by":"crossref","unstructured":"Harrison R, Vannoy S, Haynor D, Gillispie S, Kaplan M, Lewellen T. Preliminary experience with the photon history generator module of a public-domain simulation system for emission tomography. Records of IEEE Nuclear Science Symposium and Medical Imaging Conference; 1993. p. 1154\u20138.","DOI":"10.1109\/NSSMIC.1993.701828"},{"key":"778_CR43","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00259-005-1904-y","volume":"33","author":"SA Eshuis","year":"2006","unstructured":"Eshuis SA, Maguire RP, Leenders KL, Jonkman S, Jager PL. Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging. 2006;33:200\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"778_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1088\/0031-9155\/57\/21\/R119","volume":"57","author":"K Erlandsson","year":"2012","unstructured":"Erlandsson K, Buvat I, Pretorius PH, Thomas BA, Hutton BF. A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology. Phys Med Biol. 2012;57:119\u201359.","journal-title":"Phys Med Biol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-013-0778-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-013-0778-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T17:22:37Z","timestamp":1746033757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-013-0778-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s12149-013-0778-5","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,18]]}}}